Computational Anti-AIDS Drug Design Based on the Analysis of the Specific Interactions Between Immunophilins and the HIV-1 gp120 V3 Loop. Application to the FK506-Binding Protein

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Biomolecular Structure and Dynamics

• Publication date

  2008-08-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1080/07391102.2008.10507222PMID 18533725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural Analysis of the HIV-1 gp120 V3 Loop: Application to the HIV-Haiti Isolates

  2007cited by this paper
• Immunophilins: for the love of proteins

  2006cited by this paper
• AIDS Res Hum Retroviruses

  2006cited by this paper
• Docking essential dynamics eigenstructures

  2005cited by this paper
• HIV-1 gp120 V3 loop for structure-based drug design.

  2005cited by this paper
• V3: HIV's Switch-Hitter

  2005cited by this paper
• Dual Spatial Folds and Different Local Structures of the HIV-1 Immunogenic Crown in Various Virus Isolates

  2004cited by this paper
• 3D Structure Model of the Principal Neutralizing Epitope of Minnesota HIV-1 Isolate

  2004cited by this paper
• Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.

  2003cited by this paper
• Polarizable Atomic Multipole Water Model for Molecular Mechanics Simulation

  2003cited by this paper
• Local Structural Properties of the V3 Loop of Thailand HIV-1 Isolate

  2002cited by this paper
• Immunophilins and HIV-1 infection

  2002cited by this paper
• Heat shock proteins: novel therapeutic tools for HIV-infection?

  2001cited by this paper
• The Binding of a Glycoprotein 120 V3 Loop Peptide to HIV-1 Neutralizing Antibodies

  2000cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120.

  1999cited by this paper
• Host cyclophilin A mediates HIV‐1 attachment to target cells via heparans

  1999cited by this paper
• The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood.

  1998cited by this paper
• Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.

  1997cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5

  1996cited by this paper
• Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization

  1996cited by this paper
• Apoptosis‐induced concomitant release of cytosolic proteins and factors which prevent cell death

  1996cited by this paper
• Peptidylproline cis/trans isomerases.

  1995cited by this paper
• Activation of Ca2+ signaling in neutrophils by the mast cell-released immunophilin FKBP12.

  1995cited by this paper
• Secretion by Trypanosoma cruzi of a peptidyl‐prolyl cis‐trans isomerase involved in cell infection.

  1995cited by this paper
• Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1

  1995cited by this paper
• Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies.

  1995cited by this paper
• The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin.

  1994cited by this paper
• Crystal structure of the principal neutralization site of HIV-1.

  1994cited by this paper
• Functional association of cyclophilin A with HIV-1 virions

  1994cited by this paper
• Molecular determinants of the V3 loop of human immunodeficiency virus type 1 glycoprotein gp120 responsible for controlling cell tropism.

  1994cited by this paper
• Specific incorporation of cyclophilin A into HIV-1 virions

  1994cited by this paper
• Backbone-dependent rotamer library for proteins. Application to side-chain prediction.

  1993cited by this paper
• V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability

  1993cited by this paper
• Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.

  1993cited by this paper
• Immunophilins: structure—function relationship and possible role in microbial pathogenicity

  1993cited by this paper
• Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

  1992cited by this paper
• Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution

  1992cited by this paper
• Leukocyte chemotactic activity of cyclophilin.

  1992cited by this paper
• Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1.

  1992cited by this paper
• Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.

  1992cited by this paper
• Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex

  1991cited by this paper
• Alteration of HIV-1 Infectivity and Neutralization by a Single Amino Acid Replacement in the V3 Loop Domain

  1991cited by this paper
• A novel secreted cyclophilin-like protein (SCYLP).

  1991cited by this paper
• Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

  1990cited by this paper
• Calculation of conformational ensembles from potentials of mean force. An approach to the knowledge-based prediction of local structures in globular proteins.

  1990cited by this paper
• Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1

  1990cited by this paper
• Method of determining protein conformations by the two-dimensional nuclear Overhauser enhancement spectroscopy data.

  1987cited by this paper
• The Protein Data Bank: a computer-based archival file for macromolecular structures.

  1977cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach

  2013cites this paper
• Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe

  2013influential citation
• Determination of the invariant structural elements for the third variable domain of the HIV-1 gp120 protein by molecular modeling

  2011cites this paper
• Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving

  2011influential citation
• Structure-Based and Ligand-Based Drug Design for HER 2 Receptor

  2010cites this paper
• Computer-assisted anti-AIDS drug development: cyclophilin B against the HIV-1 subtype A V3 loop

  2010influential citation
• Anti-Infectious Bronchitis Virus (IBV) Activity of 1,8-cineole: Effect on Nucleocapsid (N) Protein

  2010cites this paper
• Computer modeling of promising inhibitors of the HIV-1 subtype A replication as a framework for the rational anti-AIDS drug design

  2010cites this paper
• Structural Features of the Interfaces in Enzyme-Inhibitor Complexes

  2010cites this paper
• A Conformationally Constrained Peptidomimetic Binds to the Extracellular Region of HER2 Protein

  2010cites this paper
• Immunophilins and HIV-1 V3 Loop For Structure-Based Anti-AIDS Drug Design

  2009cites this paper
• Weighted Equation and Rules—A Novel Concept for Evaluating Protein-Ligand Interaction

  2009cites this paper
• Computational Model of the HIV-1 Subtype A V3 Loop: Study on the Conformational Mobility for Structure-Based Anti-AIDS Drug Design

  2009cites this paper